-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from Q1 2020 to Q1 2025.
- Barinthus Biotherapeutics plc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2025 was -$5K, a 98.4% increase year-over-year.
- Barinthus Biotherapeutics plc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$892K, a 83.5% increase from 2023.
- Barinthus Biotherapeutics plc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$5.41M, a 5.86% increase from 2022.
- Barinthus Biotherapeutics plc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$5.75M, a 55.5% increase from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)